Understanding TIGD1’s precise regulatory mechanisms could reveal new therapeutic targets and strategies for lung cancer treatment, emphasizing the need for further studies to validate these findings in diverse models and clinical settings. This evidence concerns the gene TIGD1 and lung cancer.